- Home
- LGVN vs PIII Comparison
LGVN vs PIII Comparison
Compare LGVN & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- PIII
- Stock Information
- Founded
- LGVN 2014
- PIII 2015
- Country
- LGVN United States
- PIII United States
- Employees
- LGVN N/A
- PIII N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- PIII Medical/Nursing Services
- Sector
- LGVN Health Care
- PIII Health Care
- Exchange
- LGVN Nasdaq
- PIII Nasdaq
- Market Cap
- LGVN 27.6M
- PIII 30.8M
- IPO Year
- LGVN 2021
- PIII N/A
- Fundamental
- Price
- LGVN $1.56
- PIII $0.18
- Analyst Decision
- LGVN Strong Buy
- PIII Hold
- Analyst Count
- LGVN 3
- PIII 2
- Target Price
- LGVN $8.67
- PIII $0.25
- AVG Volume (30 Days)
- LGVN 201.8K
- PIII 712.2K
- Earning Date
- LGVN 05-13-2025
- PIII 03-27-2025
- Dividend Yield
- LGVN N/A
- PIII N/A
- EPS Growth
- LGVN N/A
- PIII N/A
- EPS
- LGVN N/A
- PIII N/A
- Revenue
- LGVN $2,392,000.00
- PIII $1,500,455,000.00
- Revenue This Year
- LGVN $26.05
- PIII $21.45
- Revenue Next Year
- LGVN $12.27
- PIII N/A
- P/E Ratio
- LGVN N/A
- PIII N/A
- Revenue Growth
- LGVN 237.38
- PIII 18.48
- 52 Week Low
- LGVN $0.77
- PIII $0.15
- 52 Week High
- LGVN $6.40
- PIII $0.85
- Technical
- Relative Strength Index (RSI)
- LGVN 45.61
- PIII 50.69
- Support Level
- LGVN $1.44
- PIII $0.16
- Resistance Level
- LGVN $1.62
- PIII $0.19
- Average True Range (ATR)
- LGVN 0.12
- PIII 0.02
- MACD
- LGVN -0.02
- PIII 0.00
- Stochastic Oscillator
- LGVN 25.00
- PIII 68.26
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.